vs
爱德华生命科学（EW）与国民油井华高（NOV）财务数据对比。点击上方公司名可切换其他公司
国民油井华高的季度营收约是爱德华生命科学的1.2倍（$2.1B vs $1.6B），爱德华生命科学净利率更高（23.1% vs 1.0%，领先22.1%），爱德华生命科学同比增速更快（16.7% vs -9.9%），过去两年爱德华生命科学的营收复合增速更高（9.7% vs -3.8%）
爱德华生命科学是总部位于美国加利福尼亚州尔湾的医疗科技企业，专注于人工心脏瓣膜及血流动力学监测领域，其研发的Sapien经导管主动脉心脏瓣膜采用牛组织材质，搭配球囊扩张式钴铬合金支架，可通过导管完成植入。
NOV Inc.（前称国民油井华高）是总部位于美国得克萨斯州休斯顿的跨国企业，为上游油气行业提供钻探及生产作业所需的设备零部件、油田服务及供应链整合服务，在六大洲布局超500个运营点，下设能源设备、能源产品与服务两大业务板块。
EW vs NOV — 直观对比
营收规模更大
NOV
是对方的1.2倍
$1.6B
营收增速更快
EW
高出26.6%
-9.9%
净利率更高
EW
高出22.1%
1.0%
两年增速更快
EW
近两年复合增速
-3.8%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.6B | $2.1B |
| 净利润 | $380.7M | $20.0M |
| 毛利率 | 78.0% | 18.5% |
| 营业利润率 | 1.8% | 2.3% |
| 净利率 | 23.1% | 1.0% |
| 营收同比 | 16.7% | -9.9% |
| 净利润同比 | 6.8% | -73.0% |
| 每股收益（稀释后） | $0.66 | $0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EWNOV
| Q1 26 | $1.6B | $2.1B | ||
| Q4 25 | $1.6B | $2.3B | ||
| Q3 25 | $1.6B | $2.2B | ||
| Q2 25 | $1.5B | $2.2B | ||
| Q1 25 | $1.4B | $2.1B | ||
| Q4 24 | $1.4B | $2.3B | ||
| Q3 24 | $1.4B | $2.2B | ||
| Q2 24 | $1.4B | $2.2B |
净利润EWNOV
| Q1 26 | $380.7M | $20.0M | ||
| Q4 25 | $91.2M | $-78.0M | ||
| Q3 25 | $291.1M | $42.0M | ||
| Q2 25 | $333.2M | $108.0M | ||
| Q1 25 | $358.0M | $73.0M | ||
| Q4 24 | $385.6M | $160.0M | ||
| Q3 24 | $3.1B | $130.0M | ||
| Q2 24 | $366.3M | $226.0M |
毛利率EWNOV
| Q1 26 | 78.0% | 18.5% | ||
| Q4 25 | 78.1% | 20.3% | ||
| Q3 25 | 77.8% | 18.9% | ||
| Q2 25 | 77.5% | 20.4% | ||
| Q1 25 | 78.7% | 21.3% | ||
| Q4 24 | 78.9% | 21.4% | ||
| Q3 24 | 80.6% | 21.4% | ||
| Q2 24 | 79.9% | 26.6% |
营业利润率EWNOV
| Q1 26 | 1.8% | 2.3% | ||
| Q4 25 | 9.6% | 4.0% | ||
| Q3 25 | 19.8% | 4.9% | ||
| Q2 25 | 26.8% | 6.5% | ||
| Q1 25 | 27.9% | 7.2% | ||
| Q4 24 | 22.6% | 9.0% | ||
| Q3 24 | 25.9% | 8.9% | ||
| Q2 24 | 26.8% | 14.1% |
净利率EWNOV
| Q1 26 | 23.1% | 1.0% | ||
| Q4 25 | 5.8% | -3.4% | ||
| Q3 25 | 18.7% | 1.9% | ||
| Q2 25 | 21.7% | 4.9% | ||
| Q1 25 | 25.3% | 3.5% | ||
| Q4 24 | 27.8% | 6.9% | ||
| Q3 24 | 226.7% | 5.9% | ||
| Q2 24 | 26.7% | 10.2% |
每股收益（稀释后）EWNOV
| Q1 26 | $0.66 | $0.05 | ||
| Q4 25 | $0.16 | $-0.20 | ||
| Q3 25 | $0.50 | $0.11 | ||
| Q2 25 | $0.56 | $0.29 | ||
| Q1 25 | $0.61 | $0.19 | ||
| Q4 24 | $0.65 | $0.40 | ||
| Q3 24 | $5.13 | $0.33 | ||
| Q2 24 | $0.61 | $0.57 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $1.3B |
| 总债务越低越好 | — | $1.7B |
| 股东权益账面价值 | — | — |
| 总资产 | — | $11.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资EWNOV
| Q1 26 | — | $1.3B | ||
| Q4 25 | $4.2B | $1.6B | ||
| Q3 25 | $3.8B | $1.2B | ||
| Q2 25 | $4.1B | $1.1B | ||
| Q1 25 | $3.9B | $1.2B | ||
| Q4 24 | $4.0B | $1.2B | ||
| Q3 24 | $4.4B | $985.0M | ||
| Q2 24 | $2.0B | $827.0M |
总债务EWNOV
| Q1 26 | — | $1.7B | ||
| Q4 25 | — | $1.7B | ||
| Q3 25 | — | $1.7B | ||
| Q2 25 | — | $1.7B | ||
| Q1 25 | — | $1.7B | ||
| Q4 24 | — | $1.7B | ||
| Q3 24 | — | $1.7B | ||
| Q2 24 | — | $1.7B |
股东权益EWNOV
| Q1 26 | — | — | ||
| Q4 25 | $10.3B | $6.3B | ||
| Q3 25 | $10.2B | $6.5B | ||
| Q2 25 | $10.5B | $6.5B | ||
| Q1 25 | $10.1B | $6.4B | ||
| Q4 24 | $10.0B | $6.4B | ||
| Q3 24 | $9.5B | $6.5B | ||
| Q2 24 | $7.4B | $6.4B |
总资产EWNOV
| Q1 26 | — | $11.1B | ||
| Q4 25 | $13.7B | $11.3B | ||
| Q3 25 | $13.3B | $11.3B | ||
| Q2 25 | $13.5B | $11.4B | ||
| Q1 25 | $13.0B | $11.3B | ||
| Q4 24 | $13.1B | $11.4B | ||
| Q3 24 | $13.0B | $11.4B | ||
| Q2 24 | $10.1B | $11.3B |
负债/权益比EWNOV
| Q1 26 | — | — | ||
| Q4 25 | — | 0.27× | ||
| Q3 25 | — | 0.27× | ||
| Q2 25 | — | 0.27× | ||
| Q1 25 | — | 0.27× | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | 0.27× | ||
| Q2 24 | — | 0.27× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | — |
| 自由现金流经营现金流 - 资本支出 | — | $51.0M |
| 自由现金流率自由现金流/营收 | — | 2.5% |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $876.0M |
8季度趋势，按日历期对齐
经营现金流EWNOV
| Q1 26 | — | — | ||
| Q4 25 | $450.9M | $573.0M | ||
| Q3 25 | $573.7M | $352.0M | ||
| Q2 25 | $290.2M | $191.0M | ||
| Q1 25 | $280.4M | $135.0M | ||
| Q4 24 | $-127.5M | $591.0M | ||
| Q3 24 | $351.8M | $359.0M | ||
| Q2 24 | $371.5M | $432.0M |
自由现金流EWNOV
| Q1 26 | — | $51.0M | ||
| Q4 25 | $353.5M | $472.0M | ||
| Q3 25 | $516.2M | $245.0M | ||
| Q2 25 | $240.9M | $108.0M | ||
| Q1 25 | $224.4M | $51.0M | ||
| Q4 24 | $-177.3M | $473.0M | ||
| Q3 24 | $299.9M | $277.0M | ||
| Q2 24 | $286.1M | $350.0M |
自由现金流率EWNOV
| Q1 26 | — | 2.5% | ||
| Q4 25 | 22.5% | 20.7% | ||
| Q3 25 | 33.2% | 11.3% | ||
| Q2 25 | 15.7% | 4.9% | ||
| Q1 25 | 15.9% | 2.4% | ||
| Q4 24 | -12.8% | 20.5% | ||
| Q3 24 | 22.1% | 12.6% | ||
| Q2 24 | 20.9% | 15.8% |
资本支出强度EWNOV
| Q1 26 | — | — | ||
| Q4 25 | 6.2% | 4.4% | ||
| Q3 25 | 3.7% | 4.9% | ||
| Q2 25 | 3.2% | 3.8% | ||
| Q1 25 | 4.0% | 4.0% | ||
| Q4 24 | 3.6% | 5.1% | ||
| Q3 24 | 3.8% | 3.7% | ||
| Q2 24 | 6.2% | 3.7% |
现金转化率EWNOV
| Q1 26 | — | — | ||
| Q4 25 | 4.94× | — | ||
| Q3 25 | 1.97× | 8.38× | ||
| Q2 25 | 0.87× | 1.77× | ||
| Q1 25 | 0.78× | 1.85× | ||
| Q4 24 | -0.33× | 3.69× | ||
| Q3 24 | 0.11× | 2.76× | ||
| Q2 24 | 1.01× | 1.91× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EW
暂无分部数据
NOV
| Energy Equipment | $1.2B | 58% |
| Energy Products and Services | $897.0M | 44% |
